Express Pharma

Wockhardt registers net sales at Rs 991 crores in Q1FY15

0 120

Wockhardt has reported its first quarter results for financial Year 2015. For the quarter ended June 30, 2014, the consolidated revenue was Rs 991 crores and profit after tax was at Rs 20 crores. The company increased its research spend significantly and the same is now at 11.2 per cent to sales at Rs 111 crores and including capital expenditure is at 11.7 per cent to sales for the quarter.

The capital expenditure of Rs 67 crores was incurred in Q1FY15. The India business recorded a growth of 18 per cent in Q1FY15. Emerging markets business grew by 10 per cent in Q1FY15. Wockhardt’s international business contributed 70 per cent of the total revenues during the quarter. The UK business remained flat in Q1FY15. The Irish market recorded a growth of 13 per cent in Q1FY15. Wockhardt’s US business declined by 60 per cent in Q1FY15 and contributed 29 per cent of the global revenues for Wockhardt in Q1FY15.

EP News Bureau- Mumbai

- Advertisement -

Leave A Reply

Your email address will not be published.